238 related articles for article (PubMed ID: 35544684)
41. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
Auffinger B; Spencer D; Pytel P; Ahmed AU; Lesniak MS
Expert Rev Neurother; 2015; 15(7):741-52. PubMed ID: 26027432
[TBL] [Abstract][Full Text] [Related]
42. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
43. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract][Full Text] [Related]
44. Targeting Key Signaling Pathways in Glioblastoma Stem Cells for the Development of Efficient Chemo- and Immunotherapy.
Helweg LP; Storm J; Witte KE; Schulten W; Wrachtrup L; Janotte T; Kitke A; Greiner JFW; Knabbe C; Kaltschmidt B; Simon M; Kaltschmidt C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361720
[TBL] [Abstract][Full Text] [Related]
45. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
46. 3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy.
Yan H; Romero-López M; Benitez LI; Di K; Frieboes HB; Hughes CCW; Bota DA; Lowengrub JS
Cancer Res; 2017 Aug; 77(15):4171-4184. PubMed ID: 28536277
[TBL] [Abstract][Full Text] [Related]
47. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
[TBL] [Abstract][Full Text] [Related]
48. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
Fukasawa K; Lyu J; Kubo T; Tanaka Y; Suzuki A; Horie T; Tomizawa A; Osumi R; Iwahashi S; Tokumura K; Murata M; Kobayashi M; Todo T; Hirao A; Hinoi E
Cancer Res Commun; 2023 Jan; 3(1):148-159. PubMed ID: 36968222
[TBL] [Abstract][Full Text] [Related]
49. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.
Tilghman J; Wu H; Sang Y; Shi X; Guerrero-Cazares H; Quinones-Hinojosa A; Eberhart CG; Laterra J; Ying M
Cancer Res; 2014 Jun; 74(11):3168-79. PubMed ID: 24710409
[TBL] [Abstract][Full Text] [Related]
50. Targeting A20 decreases glioma stem cell survival and tumor growth.
Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
52. A three-dimensional (3D) organotypic microfluidic model for glioma stem cells - Vascular interactions.
Truong D; Fiorelli R; Barrientos ES; Melendez EL; Sanai N; Mehta S; Nikkhah M
Biomaterials; 2019 Apr; 198():63-77. PubMed ID: 30098794
[TBL] [Abstract][Full Text] [Related]
53. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
54. The multifaceted mechanisms of malignant glioblastoma progression and clinical implications.
Sun R; Kim AH
Cancer Metastasis Rev; 2022 Dec; 41(4):871-898. PubMed ID: 35920986
[TBL] [Abstract][Full Text] [Related]
55. HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1.
He ZC; Liu Q; Yang KD; Chen C; Zhang XN; Wang WY; Zeng H; Wang B; Liu YQ; Luo M; Li L; Niu Q; Lu HM; Luo T; Yao XH; Guo HT; Ji JL; Cao MF; Shi Y; Ping YF; Bian XW
Cancer Lett; 2022 May; 533():215605. PubMed ID: 35219772
[TBL] [Abstract][Full Text] [Related]
56. ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage.
Liu J; Wang X; Chen AT; Gao X; Himes BT; Zhang H; Chen Z; Wang J; Sheu WC; Deng G; Xiao Y; Zou P; Zhang S; Liu F; Zhu Y; Fan R; Patel TR; Saltzman WM; Zhou J
Nat Commun; 2022 Apr; 13(1):2196. PubMed ID: 35459228
[TBL] [Abstract][Full Text] [Related]
57. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
Mala U; Baral TK; Somasundaram K
BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
[TBL] [Abstract][Full Text] [Related]
58. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma.
Tao W; Chu C; Zhou W; Huang Z; Zhai K; Fang X; Huang Q; Zhang A; Wang X; Yu X; Huang H; Wu Q; Sloan AE; Yu JS; Li X; Stark GR; Rich JN; Bao S
Nat Commun; 2020 Jun; 11(1):3015. PubMed ID: 32541784
[TBL] [Abstract][Full Text] [Related]
59. Glioblastoma CD105
Li J; Ek F; Olsson R; Belting M; Bengzon J
Acta Neuropathol Commun; 2022 Aug; 10(1):126. PubMed ID: 36038950
[TBL] [Abstract][Full Text] [Related]
60. A Cytotoxic Three-Dimensional-Spheroid, High-Throughput Assay Using Patient-Derived Glioma Stem Cells.
Quereda V; Hou S; Madoux F; Scampavia L; Spicer TP; Duckett D
SLAS Discov; 2018 Sep; 23(8):842-849. PubMed ID: 29750582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]